Search Results

Society of Clinical Oncology (ASCO) and the National Community Oncology Dispensing Association (NCODA) developed The Patient-Centered Standards for Medically Integrated Dispensing: ASCO/NCODA Standards as a new methodology to support and evaluate medically

-based initiatives to improve patient care and outcomes in renal cell carcinoma and hematologic malignancies. The intent of the RFP is to encourage academic and community-based organizations to submit proposals describing concepts and ideas for design and

the central nervous system (CNS). Although advances in clinical care options for patients have been somewhat limited, the community has seen tremendous progress in the molecular understanding of the disease and how these alterations promote cellular

treatment, that is simply not the case.” Shame and silence around a type of cancer, or as a member of a marginalized community, can pose additional barriers to high-quality care. “LGBT people fear homophobia and heteronormative values will crowd out

. NCCN welcomes original abstracts from investigators in the general oncology community; submissions will be accepted from NCCN Member Institutions, academic institutions, teaching and community hospitals, and industry. Topics may fall into the general

abstracts from investigators in the oncology community related to Best Practices in Implementation and Use of Clinical Practice Guidelines, Quality Improvement, Outcomes and Health Services Research, and NCCN Oncology Research Program (ORP)-funded Projects

, insurance companies, professional societies, patient advocacy organizations, and community organizations. In the face of escalating partisan dynamics within the “repeal and replace” debate, some policymakers are working across the aisle to ensure that

Moffitt Oncology Network of Moffitt Cancer Center in Tampa, Florida, as a community-based research affiliate for the project. Moffitt Cancer Center is one of 23 NCCN Member Institutions. Located in Lehigh Valley, Pennsylvania, LVHN is operating as an ARP

require immediate therapy. These NCCN Guidelines will raise awareness, educate the medical community at large, and provide a reference for commercial insurers to improve patient accessibility to diagnostic tools and potentially life-saving treatments

quality” that can characterize a practice or physician in this area. This work includes ongoing efforts within and among the National Quality Forum, NCCN, ASCO, The US Oncology Network (The Network), the Community Oncology Alliance, and Ontario Cancer Care